Dawes Fretzin Clinical Research Group is a clinical research site located in Indianapolis, Indiana, United States 46256.
Crixeo Health Trust Score: 84/100 (GOOD). This profile has not yet been claimed by the site owner.
Dawes Fretzin Clinical Research Group has participated in 26 clinical trials with 3 currently active.
Therapeutic areas: Psoriasis Vulgaris, Acne Vulgaris, Dermatitis, Atopic.
Sponsors: LEO Pharma, Stiefel, a GSK Company, Janssen Research & Development, LLC.
Trust Score: 84/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Dawes Fretzin Clinical Research Group has a Crixeo Trust Score of 84/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Dawes Fretzin Clinical Research Group has 26 clinical trials on record, with 3 currently active. Their work covers Psoriasis Vulgaris, Acne Vulgaris, Dermatitis, Atopic.
Yes — Dawes Fretzin Clinical Research Group holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.